Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rune Smaaland

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Annals of Surgical Oncology|July 4, 2012
Prognostic relevance of occult metastases detected by cytokeratin 20 and mucin 2 mRNA levels in sentinel lymph nodes from colon cancer patientsOddmund Nordgård, Satu Oltedal, Ole Gunnar Aasprong, et al.
Translational Oncology|February 24, 2018
The Prognostic Relevance of Sentinel Lymph Node Metastases Assessed by PHGR1 mRNA Quantification in Stage I to III Colon CancerSatu Oltedal, Hartwig Kørner, Ole Gunnar Aasprong, et al.
Chronobiology International|August 24, 2011
Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963)Pasquale F Innominato, Sylvie Giacchetti, Thierry Moreau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study groupTorgrim Tandstad, Rune Smaaland, Arne Solberg, et al.
Cancer|May 2, 2013
Fatigue and weight loss predict survival on circadian chemotherapy for metastatic colorectal cancerPasquale F Innominato, Sylvie Giacchetti, Thierry Moreau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy GroupSylvie Giacchetti, Georg Bjarnason, Carlo Garufi, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Annals of Surgical Oncology|July 4, 2012
Prognostic relevance of occult metastases detected by cytokeratin 20 and mucin 2 mRNA levels in sentinel lymph nodes from colon cancer patientsOddmund Nordgård, Satu Oltedal, Ole Gunnar Aasprong, et al.
Translational Oncology|February 24, 2018
The Prognostic Relevance of Sentinel Lymph Node Metastases Assessed by PHGR1 mRNA Quantification in Stage I to III Colon CancerSatu Oltedal, Hartwig Kørner, Ole Gunnar Aasprong, et al.
Chronobiology International|August 24, 2011
Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963)Pasquale F Innominato, Sylvie Giacchetti, Thierry Moreau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study groupTorgrim Tandstad, Rune Smaaland, Arne Solberg, et al.
Cancer|May 2, 2013
Fatigue and weight loss predict survival on circadian chemotherapy for metastatic colorectal cancerPasquale F Innominato, Sylvie Giacchetti, Thierry Moreau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy GroupSylvie Giacchetti, Georg Bjarnason, Carlo Garufi, et al.
Pageof 4